During the past decade, Hospital Universitario de Gran Canaria Dr. Negrin conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 23 clinical trials were completed, i.e. on average, 23.2% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 20 clinical trials were completed. i.e. 40.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario de Gran Canaria Dr. Negrin" #1 sponsor was "PETHEMA Foundation" with 16 trials, followed by "Celgene" with 9 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Bernardino Clavo, MD, PhD" with 5 trials sponsored and "Pfizer" with 5 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario de Gran Canaria Dr. Negrin" #1 collaborator was "Instituto de Salud Carlos III" with 5 trials as a collaborator, "Novartis" with 4 trials as a collaborator, "Red de Investigación en Servicios de Salud en Enfermedades Crónicas" with 4 trials as a collaborator, "Servicio Canario de Salud" with 4 trials as a collaborator and "Hoffmann-La Roche" with 3 trials as a collaborator. Other collaborators include 77 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario de Gran Canaria Dr. Negrin" are "Multiple Myeloma" (7 trials), "Ulcerative Colitis" (7 trials), "Acute Myeloid Leukemia" (4 trials), "Atopic Dermatitis" (4 trials) and "Breast Cancer" (4 trials). Many other conditions were trialed in "Hospital Universitario de Gran Canaria Dr. Negrin" in a lesser frequency.

Most popular intervention types in "Hospital Universitario de Gran Canaria Dr. Negrin" are "Drug" (84 trials), "Other" (17 trials), "Device" (6 trials), "Procedure" (6 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Dexamethasone" (7 trials), "Bortezomib" (4 trials), "KRT-232" (4 trials) and "Cytarabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario de Gran Canaria Dr. Negrin" are 117 trials for "All" genders, 5 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario de Gran Canaria Dr. Negrin". undefined are not yet recruiting, 32 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 58 completed trials in Hospital Universitario de Gran Canaria Dr. Negrin, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario de Gran Canaria Dr. Negrin, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 5 trials that are defined as “Not Applicable".